The COLUMBA study supported the long-term safety and efficacy of mepolizumab in patients with severe eosinophilic asthma.
Researchers believe these findings will lead to more extensive application of EBUS-TBNA as a single technique for concomitant use in lung cancer diagnosis and staging.
An inside look into the ILD Clinic of a large, tertiary referral center.
A new study shows serum chloride can help predict mortality in patients with pulmonary arterial hypertension. Lower level at six-month postdiagnosis is linked to larger left atrium and higher pulmonary wedge pressure.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A bone marrow transplant recipient receives a lung transplant to treat idiopathic pneumonia syndrome. This complex case illustrates close collaboration among Cleveland Clinic’s transplant, critical care and consultant teams.
Persistent MRSA in patients with CF is not easy to prevent or treat, but stringent infection control practices can reduce transmission and optimize outcomes.
Since multiple conditions can mimic components of PAH, the clinician should think about the patient’s total clinical condition before diagnosing and categorizing it. Proper evaluation and etiologic definition are crucial to providing the appropriate therapy and prognosis.
The SENSCIS® study, co-led by Cleveland Clinic’s Kristin Highland, MD, explores the use of nintedanib in patients with scleroderma-associated interstitial lung disease.
Nitric oxide is a biomarker of airway inflammation in asthma, but does it cause the inflammation? A new study finds one more piece to the puzzle.
Approved vasodilation therapies generally don’t improve function in patients with pulmonary hypertension associated with connective tissue disease. The Catalyst study explores the use of bardoxolone in these patients.